Benzenesulfonamide Analogs: Synthesis, Anti-GBM Activity and Pharmacoprofiling

The tropomyosin receptor kinase A (TrkA) family of receptor tyrosine kinases (RTKs) emerge as a potential target for glioblastoma (GBM) treatment. Benzenesulfonamide analogs were identified as kinase inhibitors possessing promising anticancer properties. In the present work, four known and two novel...

Descripción completa

Detalles Bibliográficos
Autores principales: Murugesan, Akshaya, Konda Mani, Saravanan, Thiyagarajan, Ramesh, Palanivel, Suresh, Gurbanov, Atash V., Zubkov, Fedor I., Kandhavelu, Meenakshisundaram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418358/
https://www.ncbi.nlm.nih.gov/pubmed/37569654
http://dx.doi.org/10.3390/ijms241512276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418358/
https://www.ncbi.nlm.nih.gov/pubmed/37569654
http://dx.doi.org/10.3390/ijms241512276

Ejemplares similares